Cases Studies

In 2017, a power transmission company entered Brazil with large-scale projects and faced skepticism due to its unfamiliarity in the market and the sensitivity of its flagship project across the Amazon. Speyside led strategic communications and stakeholder engagement, emphasizing the project’s benefits and addressing key concerns like licensing and social tensions. As a result, the company secured environmental licenses ahead of schedule, gained tax incentives, and built credibility through strong relationships with media, influencers, and authorities in Brazil’s energy sector.

From 2021 to 2024, a pharmaceutical company addressed challenges in Latin America’s self-care market—fragmentation and health-related misinformation—by launching a strategic communications campaign. Speyside developed tailored narratives and a regional strategy to promote over-the-counter medicines, disease awareness, and responsible self-care. The effort resulted in over 350 media clippings across top outlets and positioned company leaders and experts as credible voices, strengthening the company’s leadership in the region’s consumer healthcare space.

In 2018, a global media company in Latin America faced low brand awareness and growing competition from unreliable information sources. To protect its market position, the company partnered with Speyside to strengthen its visibility and credibility. Speyside implemented a strategy focused on executive thought leadership and stakeholder engagement. Within one year, the company secured 716 media placements—83% in top-tier outlets—solidifying its reputation and establishing its executives as trusted thought leaders in a fragmented information environment.

A growing Mexican fintech unicorn partnered with Speyside to enhance its brand visibility and public presence. Facing a competitive market, the company needed to build strong recognition and position its leaders as industry authorities. Speyside implemented a communications strategy focused on thought leadership and media engagement. Within a year, they secured 30 top-tier media interviews and over 100 impactful publications, boosting brand awareness and earning the company recognition in prestigious rankings like Expansión’s 41+1 Leaders, LinkedIn’s Best 10 Startups to Work For, and Great Place to Work.

To support diabetes policy reform in Mexico, a pharmaceutical company worked with Speyside to go beyond glucose control and emphasize the prevention of cardiovascular and kidney complications. Speyside implemented a multi-phase strategy that included stakeholder mapping, policy analysis, communication campaigns, and workshops. The project engaged policy champions and strengthened collaboration between patient groups, health professionals, and policymakers—laying the groundwork for a national response that prioritizes early diagnosis, prevention, and better treatment outcomes.

A pharmaceutical company partnered with Speyside to improve awareness around hemophilia in Mexico, focusing on the challenges of treatment adherence. Speyside assessed the healthcare landscape, mapped stakeholders, and led educational initiatives to build advocacy capacity. The project produced a strategic policy brief, hosted symposiums, and launched an ambassador program. As a result, it identified key barriers, strengthened patient organizations, and laid the groundwork for sustained advocacy and improved health outcomes.

A pharmaceutical company sought to lead efforts in understanding Mexico’s healthcare landscape for Syncytial Respiratory Virus (SRV), especially to improve infant care. Speyside organized a focus group with medical experts and civil society, using stakeholder mapping and support materials to gather insights. The result was a final report with public policy recommendations. These insights helped the company understand challenges in the public healthcare system and provided a clear foundation for future advocacy and engagement with decision-makers.

In 2017, a pharmaceutical company specializing in rare diseases asked Speyside to support and strengthen Patient Advocacy Groups (PAGs) in Brazil, which at the time operated in isolation and lacked coordination. Speyside conducted surveys and interviews to identify weaknesses and training needs, later organizing a webinar on regulatory processes and a hands-on workshop on public policy and advocacy. As a result, PAGs aligned on shared advocacy goals for 2018 and developed a roadmap for joint action—laying the foundation for a stronger, more unified rare disease advocacy network in the country.

Speyside supported a pharmaceutical company in advancing cancer policies in Brazil and facilitating the inclusion of an innovative metastatic melanoma treatment in the public health system (SUS). The work involved regulatory and stakeholder analysis, engagement with decision-makers during CONITEC’s technology incorporation process, and continuous monitoring amid COVID-19 disruptions. These efforts positioned the product as one of the top two treatment options within CONITEC and provided the company with critical insights and ministry connections to support the incorporation process.